Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds William Blair Downgrades Actinium Pharmaceuticals to Market Perform

William Blair Downgrades Actinium Pharmaceuticals to Market Perform

William Blair analyst Andy Hsieh downgrades Actinium Pharmaceuticals (AMEX:ATNM) from Outperform to Market Perform.

February 21, 2023

1 minute read

William Blair analyst Andy Hsieh downgrades Actinium Pharmaceuticals (AMEX:ATNM) from Outperform to Market Perform.

These Analysts Revise Price Targets On GitLab Following Q3 Results

December 6, 12:05 PM

GitLab Inc. (NASDAQ: GTLB) reported better-than-expected results for its third quarter and issued strong forecast for FY23.

July 14, 3:42 PM

As one of the wealthiest individuals in the world, Warren Buffett's business and life advice is frequently sought after by investors.

July 13, 4:45 PM

Over the past three months, shares of Yum Brands Inc. (NYSE:YUM) fell by 1.18%. When understanding a companies…

February 8, 11:49 AM

Morgan Stanley analyst Dillon Cumming maintains PACCAR (NASDAQ:PCAR) with a Overweight.